Dr. Jack Jacobs receives NevadaBio honor for Parkinson's research

Zhittya Genesis Medicine has announced that its President, Dr. Jack Jacobs, will receive an honor from NevadaBio at the Annual Awards Dinner. This recognition is for his significant research breakthroughs in treating Parkinson's disease. The event will take place on April 2, 2025, at the Durango Hotel in Las Vegas. Dr. Jacobs led a team that developed a treatment called FGF-1, which helps create new blood vessels in the brain. This therapy has shown positive results in over 200 patients, helping them improve motor skills and overall quality of life. Dr. Jacobs believes that this work could also be applied to other conditions related to poor blood flow, such as heart disease and stroke. At the awards dinner, NevadaBio will celebrate achievements in biotechnology and the health sciences in Nevada. Attendees will learn about the economic benefits of local biotech innovations and how research can lead to real-world medical solutions. NevadaBio is focused on supporting the growth of biotechnology in the state through education and collaboration. Recognizing Dr. Jacobs and Zhittya's advancements highlights Nevada's emerging role as a center for important medical research and development.